Abstract
Coeliac disease is a T-cell-mediated enteropathy induced by gluten. A minority of patients who fail to respond to a gluten-free diet may require intervention with immunomodulating drugs. We report a case of refractory coeliac disease where remission was induced by the anti-tumour necrosis factor-alpha antibody infliximab and was maintained with prednisolone and azathioprine.
| Translated title of the contribution | Refractory coeliac disease: remission with infliximab and immunomodulators |
|---|---|
| Original language | English |
| Pages (from-to) | 667 - 669 |
| Number of pages | 3 |
| Journal | European Journal of Gastroenterology and Hepatology |
| Volume | 17(6) |
| Publication status | Published - Jun 2005 |